Actively Recruiting
GALENOS 1 in Head and Neck, Lung, and Rectal Cancer Patients
Led by Fondazione del Piemonte per l'Oncologia · Updated on 2026-04-06
110
Participants Needed
1
Research Sites
170 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
GALENOS 1 is a prospective observational study designed to explore longitudinal changes in nutritional status and body composition in patients with head and neck squamous cell carcinoma, locally advanced rectal cancer, and lung cancer undergoing standard antineoplastic treatments. The study is the preparatory observational component of the FOR-GALE PREVENTION project, which aims to support the future development of a galenic immunonutrition dietary supplement intended to reduce adverse events and improve treatment compliance
CONDITIONS
Official Title
GALENOS 1 in Head and Neck, Lung, and Rectal Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Written informed consent provided before study procedures
- Male or female participants aged 18 years or older
- Histological or cytological documentation of head and neck squamous cell carcinoma, locally advanced rectal cancer, or lung cancer
- Candidate for standard antineoplastic treatment according to clinical practice
- ECOG Performance Status score less than 2
- Adequate kidney, liver, and bone marrow function
- Ability to adhere to study visits and protocol requirements
You will not qualify if you...
- Incomplete recovery from surgery before start of antineoplastic treatment
- Other additional malignancies progressing or requiring active treatment within the previous 3 years, except localized basal cell carcinoma, localized squamous cell carcinoma of the skin, or cervical carcinoma in situ
- Active infection requiring systemic antibiotic therapy
- Serious or unstable medical conditions, psychiatric disorders, or substance abuse that would interfere with study compliance
- Receipt of any live vaccine within 30 days before planned start of study therapy
- Active cardiac pacing/pacing implants/neurostimulators/hearing systems not compatible with bioimpedance analysis
- Edema and/or ascites interfering with body weight evaluation or bioimpedance analysis
- Enteral or parenteral nutritional support at baseline
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fondazione del Piemonte per l'Oncologia- IRCCS Istituto di Candiolo, Candiolo, Turin 10060
Candiolo, Torino (TO), Italy, 10060
Actively Recruiting
Research Team
V
Valentina Casalone, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here